JRV Revenue and Competitors
Estimated Revenue & Valuation
- JRV's estimated annual revenue is currently $3.5M per year.
- JRV's estimated revenue per employee is $500,000
Employee Data
- JRV has 7 Employees.
- JRV grew their employee count by -79% last year.
JRV's People
Name | Title | Email/Phone |
---|---|---|
1 | Directrice des ventes | Reveal Email/Phone |
JRV Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15M | 46 | -15% | N/A | N/A |
#2 | $7.5M | 43 | 0% | N/A | N/A |
#3 | $35M | 70 | 4% | N/A | N/A |
#4 | $3.5M | 59 | 34% | N/A | N/A |
#5 | $3.5M | 56 | 8% | N/A | N/A |
#6 | N/A | 53 | -44% | N/A | N/A |
#7 | N/A | 28 | 8% | N/A | N/A |
#8 | $75M | 1098 | 4% | N/A | N/A |
#9 | $75M | 92 | 3% | N/A | N/A |
#10 | $35M | 295 | 8% | N/A | N/A |
What Is JRV?
Since 1995 JRV Inc. has provided high quality laboratory and pharmacy refrigerators and freezers at affordable prices to laboratories, hospitals, pharmacies, medical facilitates, blood banks, universities, colleges, dairies and wineries. We supply a complete line of undercounter, upright, general purpose and chest style refrigerators and freezers. Our upright and undercounter refrigerators and freezers are ideal for storing vaccines, serums, specimens, etc. While our moderate cold (-40C) and ultra cold (-85C) chest style freezers are ideal for storing cultures used by dairies and wineries. We also supply moderate cold and ultra cold chest style freezers to adhesive companies. Our products include a warranty. We pride ourselves in providing excellent customer service to our patrons.
keywords:N/AN/A
Total Funding
7
Number of Employees
$3.5M
Revenue (est)
-79%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.1M | 8 | -27% | N/A |
#2 | $0.6M | 8 | N/A | N/A |
#3 | $1.3M | 9 | -65% | N/A |
#4 | $1.7M | 9 | -10% | N/A |
#5 | $1.8M | 11 | -69% | N/A |